Sonai
Development- Indications
- Inflammatory bowel disease, Ulcerative colitis, Crohn's disease
Company intelligence / Profile preview
Dova Health Intelligence has developed an explainable AI platform that automates scoring and interpretation of gastrointestinal endoscopy videos. Its lead product enables more granular and objective assessment of ulcerative colitis severity in clinical trials. The system leverages a large global dataset with expert-labeled colonoscopy videos. Commercial launch with major CRO partners began in mid–2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dova Health Intelligence.